We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High-Throughput Micro-Aperture Chip System Detects Cancer Cells

By LabMedica International staff writers
Posted on 24 Oct 2013
A system is being developed that uses tiny magnetic beads to quickly detect rare types of cancer cells circulating in a patient's blood. More...


The microchip system is based on a combination of immunomagnetic separation and microfluidics for high-throughput detection of whole cells and in this system target cells bound to magnetic beads flow parallel to a microchip.

Scientists at Purdue University (West Lafayette, IN, USA) combined the two techniques of immunomagnetic separation and microfluidics. In immunomagnetic separation, magnetic beads about a micron in diameter are "functionalized," or coated with antibodies that recognize and attach to antigens on the surface of target cells. The functionalized beads recognize breast cancer and lung cancer cells in laboratory cultures.

The updated design passes the fluid through a chamber that allows for faster flow; a standard 7.5 mL fluid sample can run through the system in a matter of minutes. The beads are directed by a magnetic field to a silicon mesh containing holes 8 µm in diameter. Because the target cells are so sparse, many of the beads fail to attract any and pass through the silicon mesh. The beads that have attached to cells are too large to pass through the holes in the mesh.

The cells can be analyzed clearly under a microscope and released from the chip for further analysis by removing the magnetic field. The system was characterized by detecting human breast adenocarcinoma cell line (MCF-7) and adenocarcinomic human alveolar basal epithelial cells (A549) in culture media using anti- epithelial cell adhesion molecule (EpCAM) conjugated magnetic beads.

Cagri A. Savran, PhD, an associate professor of Biomedical Engineering at Purdue, said, “We were able to detect cancer cells with up to a 90% yield. We expect this system to be useful in a wide variety of settings, including detection of rare cells for clinical applications. What's new here is that we've built a system that can perform all of these steps on one chip. It both separates cells and also places them on a chip surface so you can count them and study them with a microscope.” The study was highlighted on September 18, 2013, in the journal Lab on a Chip.

Related Links:

Purdue University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.